Literature DB >> 2535035

Chromosome 1 deletions in human neuroblastomas: generation and fine mapping of microclones from the distal 1p region.

T Martinsson1, A Weith, C Cziepluch, M Schwab.   

Abstract

Human neuroblastomas show a high incidence of deletions in the distal region of the short arm of chromosome 1. In pursuit of a molecular analysis of these deletions, we have generated a microclone bank from microdissected 1p35-pter chromosomal fragments. To allow a rapid localization of the microclones, we have also generated a panel of (human x mouse) hybrid cell lines through microcell-mediated chromosome transfer. The hybrid cells contained different portions of the human chromosome 1 on a murine background. A total of 20 randomly chosen single or low-copy microclones were localized by Southern analysis on DNA of the hybrid panel: All probes were derived from chromosome I. Sixteen mapped in region 1p36.1-pter, two in 1p22-p36.1, and another two in 1cen-qter. The mapping of ten of these microclones was further refined by in situ hybridization. Cells of the neuroblastoma line GI-ME-N carry two types of chromosome 1, one cytogenetically normal and another with a translocation reported to be in 1p36.2, i.e., a t(1;?) (p36.2;?) marker. Using cell hybridization, we separated the two chromosome 1 types of GI-ME-N into different hybrid cell clones. Southern hybridization of three microclones from distal Ip to DNA of the hybrid cell clones revealed that the breakpoint in the translocated chromosome I was located in 1p36.1.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2535035     DOI: 10.1002/gcc.2870010111

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  9 in total

1.  Intrachromosomal rearrangements fusing L-myc and rlf in small-cell lung cancer.

Authors:  T P Mäkelä; J Kere; R Winqvist; K Alitalo
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

Review 2.  Neuroblastoma tumour genetics: clinical and biological aspects.

Authors:  N Bown
Journal:  J Clin Pathol       Date:  2001-12       Impact factor: 3.411

3.  MYCN Amplification in Neuroblastoma: a Paradigm for the Clinical Use of an Oncogene.

Authors:  Manfred Schwab
Journal:  Pathol Oncol Res       Date:  1997       Impact factor: 3.201

4.  Translocation involving 1p and 17q is a recurrent genetic alteration of human neuroblastoma cells.

Authors:  L Savelyeva; R Corvi; M Schwab
Journal:  Am J Hum Genet       Date:  1994-08       Impact factor: 11.025

5.  Olfactory neuroblastoma is a peripheral primitive neuroectodermal tumor related to Ewing sarcoma.

Authors:  P H Sorensen; J K Wu; K W Berean; J F Lim; W Donn; H F Frierson; C P Reynolds; D López-Terrada; T J Triche
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

6.  A modifying locus for familial adenomatous polyposis may be present on chromosome 1p35-p36.

Authors:  I P Tomlinson; K Neale; I C Talbot; A D Spigelman; C B Williams; R K Phillips; W F Bodmer
Journal:  J Med Genet       Date:  1996-04       Impact factor: 6.318

7.  Mutually exclusive expression of a helix-loop-helix gene and N-myc in human neuroblastomas and in normal development.

Authors:  W Ellmeier; A Aguzzi; E Kleiner; R Kurzbauer; A Weith
Journal:  EMBO J       Date:  1992-07       Impact factor: 11.598

8.  Bioinformatics analysis of recurrent deletion regions in neuroblastoma.

Authors:  Hasan Onur Caglar
Journal:  Med Oncol       Date:  2022-01-20       Impact factor: 3.064

9.  Detailed deletion mapping of chromosome band 14q32 in human neuroblastoma defines a 1.1-Mb region of common allelic loss.

Authors:  M Hoshi; N Otagiri; H O Shiwaku; S Asakawa; N Shimizu; Y Kaneko; R Ohi; Y Hayashi; A Horii
Journal:  Br J Cancer       Date:  2000-06       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.